BIOMAT Database Logo BIOMAT Database Logo

[Results of cytosine arabinoside treatment in adult patients with acute myeloblastic leukemia]. 1973

M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski
[Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
October 1972, Ugeskrift for laeger,
M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski
[Treatment of acute myeloblastic leukemia in elderly patients with low-dose cytosine arabinoside].
April 1985, Presse medicale (Paris, France : 1983),
M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski
Brain perfusion in adult patients with acute myeloblastic leukemia before and after cytosine arabinoside.
August 2011, Molecular imaging and biology,
M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski
Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukemia in older patients.
July 1995, Annals of hematology,
M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski
Low-dose cytosine arabinoside in patients with acute myeloblastic leukemia and myelodysplastic syndrome.
January 1987, Haematology and blood transfusion,
M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski
Cytosine arabinoside and 6-thioguanine in the treatment of childhood acute myeloblastic leukemia.
September 1977, Cancer,
M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski
[Low-dose cytosine arabinoside in the treatment of myeloblastic leukemia].
September 1984, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski
[Cytosine-arabinoside in the treatment of acute myeloblastic leukemias].
March 1971, Minerva medica,
M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski
Cytosine arabinoside in the treatment of acute myeloblastic leukaemia.
June 1971, Lancet (London, England),
M Gepner-Woźniewska, and A Retmańska, and Z Sobczynska-Czechowska, and S Pawelski
[Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
January 1978, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Copied contents to your clipboard!